Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    VMAT2
Show Display Options
Rank Status Study
1 Completed 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
2 Active, not recruiting Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Conditions: Healthy Volunteers;   Diabetes Mellitus, Type 1
Intervention: Radiation: 18F-FP-DTBZ uptake
3 Completed PET Scan Imaging of Beta Cell Mass
Conditions: Type 1 Diabetes;   Obesity
4 Recruiting Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy
Conditions: Stage III Non-small Cell Lung Cancer;   Individualized Radiation Dose Escalation
Intervention: Radiation: Individualized dose escalation
5 Recruiting Tumor TARGET Prostate Cancer
Condition: Patients With Prostate Cancer.
Interventions: Radiation: Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy;   Other: No Active Treatment - completed Prior Radiation
6 Completed Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
Conditions: Lysosomal Storage Disease;   Peroxisomal Disorder
Interventions: Drug: Campath-1H;   Drug: Clofarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation with Marrow Boosting;   Biological: Hematopoietic stem cell transplantation;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil
7 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
8 Recruiting Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Radiation: volumetric-modulated arc therapy;   Drug: metformin hydrochloride;   Other: laboratory biomarker analysis
9 Not yet recruiting Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Condition: Rectal Neoplasms
Interventions: Radiation: Early PET/CT - 2 weeks after commencing chemo/RT;   Other: Early MRI - 2 weeks after commencing chemo/RT;   Radiation: PET/CT 6 weeks post chemo/RT;   Other: MRI 6 weeks post chemo/RT
10 Recruiting Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
Condition: Resectable Rectal Carcinoma
Interventions: Drug: FOLFOX4;   Radiation: Tomotherapy;   Procedure: TME (Total Mesorectal Excision)
11 Recruiting Hypofractionated IMRT With Temozolomide for HGG
Condition: Glioma
Intervention: Radiation: Hypofractionated IMRT
12 Recruiting A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
Conditions: Stomach Neoplasms;   Chemoradiotherapy, Adjuvant;   Radiotherapy, Intensity-Modulated
Interventions: Radiation: intensity-modulated radiotherapy;   Drug: S-1
13 Recruiting Hypofractionated Imrt (Vmat-Ra) For Elderly Patients With Newly Diagnosed High Grade Glioma
Condition: Glioma
Intervention: Radiation: Radiation
14 Active, not recruiting Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases
Condition: Brain Metastases
Intervention: Radiation: whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy
15 Recruiting Phase II Image Guided Stereotactic Ablative Radiotherapy for Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Radiation: Image Guided Stereotatic Ablative Radiotherapy
16 Completed Protocole Advanced RadioTherapy ORL
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Radiation: Radiotherapy
17 Recruiting Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc
Condition: Neoplasm Metastasis
Intervention: Radiation: VMAT
18 Active, not recruiting Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery
Condition: Prostate Cancer
Intervention: Radiation: radiation therapy
19 Not yet recruiting Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases
Condition: Brain Metastases
Interventions: Radiation: Single-fraction radiotherapy;   Radiation: Whole-brain radiotherapy
20 Not yet recruiting Real-Time MV/kV Image Guided Radiation Therapy
Condition: Prostate Cancer
Intervention: Device: Real-time kV/MV Prostate Imaging

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years